KRRO-110 is designed to co-opt an endogenous enzyme, Adenosine Deaminase Acting on RNA’s (ADAR), to edit the “A” variant on SERPINA1 RNA, repair an amino acid codon, and restore secretion of normal ...

One technique involves a group of enzymes called adenosine deaminase acting on RNA (ADAR). Adenosine is one of the building ...

AX-0810 targeting NTCP for cholestatic diseases to be first ProQR Axiomer™ RNA editing program to enter the clinic Company to host virtual ...

Korro Bio has taken note of data from peers in the field that dispels previous doubts about the efficacy of ADAR (adenosine deaminase acting on RNA) drugging in humans. This breakthrough is considered ...

Those enzymes are named after what they do — adenosine deaminase that acts on RNA, or ADAR — and the changes they make can alter a protein’s shape or function. For instance, squids use ADARs to ...

Adar Poonawalla is acquiring a 50% stake in Karan Johar's Dharma Production and Dharmatic Entertainment for Rs 1,000 crore, valuing the company at Rs 2000 crore, according to a report. Johar ...

Adar Poonawalla, the billionaire CEO of Serum Institute of India, has built a reputation for his luxurious lifestyle and high-profile business ventures. From a fleet of supercars to private jets ...

The vaccine maker's foray into the film industry is expected to be a boost for the Karan Johar-owned production house, which has seen its earnings decline due to multiple factors. The vaccine ...

Vertex may have pivoted away from the space, but candidates in development by Arrowhead/Takeda, Wave, Korro and others could ...

Billionaire Adar Poonawalla-led Serum Institute of India has held discussions with global private equity firm TPG to sell 40% stake held by the top vaccine maker in SCHOTT Poonawalla, four people ...

Adar Poonawalla’s Serene Productions is all set to acquire a 50 per cent stake in Karan Johar’s Dharma Productions and ...